product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IL-22BP Fc Chimera Protein, CF
catalog :
1087-BP-025
quantity :
25 ug
price :
432 USD
more info or order :
citations: 5
Reference
Wang Y, Mumm J, Herbst R, Kolbeck R, Wang Y. IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression. J Immunol. 2017;199:3316-3325 pubmed publisher
Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation. 2015;12:119 pubmed publisher
Witte K, Gruetz G, Volk H, Looman A, Asadullah K, Sterry W, et al. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 2009;10:702-14 pubmed publisher
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-54 pubmed
Donnelly R, Sheikh F, Kotenko S, Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol. 2004;76:314-21 pubmed
product information
brand :
R&D Systems
master code :
1087-BP
SKU :
1087-BP-025
product name :
Recombinant Human IL-22BP Fc Chimera Protein, CF
unit size :
25 ug
seo description :
The Recombinant Human IL-22BP Fc Chimera Protein, CF from R&D Systems is derived from NS0. The Recombinant Human IL-22BP Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
IL-22BP
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
dilution :
Bioactivity
purity :
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
observed molecular weight :
75-80 kDa, reducing conditions
theoretical molecular weight :
51.3 kDa (monomer)
gene symbol :
IL22RA2
details of functionality :
Measured by its ability to inhibit IL-22-induced IL-10 secretion by COLO 205 human colorectal adenocarcinoma cells. The ED50 for this effect is 4-20 ng/mL in the presence of 1 ng/mL of Recombinant Human IL-22 (Catalog # 782-IL ).
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
NP_851826
applications :
Bioactivity
source :
NS0-derived Recombinant Human IL-22BP Fc Chimera Protein, CF
USD :
432 USD
alt names :
class II cytokine receptor, CRF2-10, CRF2-S1IL22BP, CRF2-X, Cytokine receptor class-II member 10, Cytokine receptor family 2 member 10, Cytokine receptor family type 2, soluble 1, IL-22 RA2, IL-22 receptor subunit alpha-2, IL22BP, IL-22BPCRF2X, IL22RA2, IL-22RA2, IL-22R-alpha-2, interleukin 22 receptor, alpha 2, interleukin 22-binding protein, interleukin-22 receptor subunit alpha-2, Interleukin-22-binding protein, MGC150509, MGC150510, zcytoR16
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.